Evidence map›Paper›PMID 33614247›Full record

ArticleMolecular therapy. Nucleic acids2021

hsa_circNFXL1_009 modulates apoptosis, proliferation, migration, and potassium channel activation in pulmonary hypertension.

Xin Jin, Yuanyuan Xu, Min Guo, Yushuang Sun, Junzhu Ding, Lu Li, Xiaodong Zheng, Shuzhen Li, Dandan Yuan, Shan-Shan Li

Abstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. The role of circular RNAs in pulmonary hypertension.The European respiratory journal · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xin JinSchool of Medicine, Nankai University, Tianjin, China.
Yuanyuan XuDepartment of Cardiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Min GuoDepartment of Endocrinology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Yushuang SunDepartment of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University, Harbin, China.
Junzhu DingDepartment of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University, Harbin, China.
Lu LiSchool of Medicine, Nankai University, Tianjin, China.
Xiaodong ZhengDepartment of Genetics and Cell Biology, Harbin Medical University-Daqing, Daqing, China.
Shuzhen LiDepartment of Immunology, College of Basic Medical Sciences, Shenyang Medical College, Shenyang, China.
Dandan YuanDepartment of Gynecology and Obstetrics, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Shan-Shan LiSchool of Medicine, Nankai University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we explored the circular RNA (circRNA) profile in pulmonary arterial hypertension (PAH) patients caused by chronic obstructive pulmonary disease (COPD) and the effects of hsa_circNFXL1_009 on abnormal proliferation, apoptosis, and migration of human pulmonary arterial smooth muscle cells (hPASMCs) driven by hypoxia. Using microarrays, we screened the circRNA profile in whole-blood samples from three pairs of subjects and found 158 dysregulated circRNAs in patients with PAH-COPD. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis further validated that hsa_circNFXL1_009 was dramatically downregulated with the highest area under a receiver operating characteristic curve (ROC) in 21 pairs of subjects. Consistently, exposure to hypoxia markedly reduced the hsa_circNFXL1_009 level in cultured hPASMCs. Delivery of exogenous hsa_circNFXL1_009 attenuated hypoxia-induced proliferation, apoptotic resistance, and migration of hPASMCs, as evidenced by immunocytochemistry, 5-ethynyl-2'-deoxyuridine incorporation, wound healing, and a TUNEL (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling) assay. A luciferase assay showed that hsa_circNFXL1_009 directly sponged hsa-miR-29b-2-5p (miR-29b) and positively regulated the expression of voltage-gated potassium (K

Indexed as

circular RNAhypoxiapulmonary arterial hypertensionremodeling

Identifiers

PMID33614247
PMCPMC7868929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.